Abstract
Few studies have examined the association between healthcare utilization and heavy alcohol use in Russia among persons with HIV (PWH), a group with high healthcare needs. This study analyzed the association between unhealthy alcohol use (defined as AUDIT score ≥ 8) and healthcare utilization among PWH with heavy alcohol use and daily smoking in St. Petersburg, Russia. This secondary analysis used data from a randomized controlled trial addressing alcohol use. The primary outcome was seeing an infectionist for HIV care in the past year. Outcomes were measured at baseline, 6 months, and 12 months. We assessed the association between unhealthy alcohol use and healthcare utilization outcomes with a repeated measures logistic regression model, controlling for relevant covariates. Nearly all (96.0%) participants had unhealthy alcohol use at baseline, and 90.0% had seen an infectionist for HIV care in the past year. In adjusted analyses, unhealthy alcohol use was associated with a 36% decrease in seeing an infectionist for HIV care (aOR = 0.64, 95% CI 0.43–0.95). Participants reported low levels of emergency department visits and hospitalizations. Understanding how to engage this population in alcohol use disorder treatment and HIV care is an important next step for improving health outcomes for this population.
Similar content being viewed by others
References
World Health Organization. Global status report on alcohol and health 2018. [Internet]. 2018. https://apps.who.int/iris/bitstream/handle/10665/274603/9789241565639-eng.pdf?ua=1
Shield K, Manthey J, Rylett M, Probst C, Wettlaufer A, Parry CDH, et al. National, regional, and global burdens of disease from 2000 to 2016 attributable to alcohol use: a comparative risk assessment study. The Lancet Public Health. 2020;5(1):e51-61.
Zaridze D, Lewington S, Boroda A, Scélo G, Karpov R, Lazarev A, et al. Alcohol and mortality in Russia: prospective observational study of 151 000 adults. The Lancet. 2014;383(9927):1465–73.
Beyrer C, Wirtz AL, O’Hara G, Léon N, Kazatchkine M. The expanding epidemic of HIV-1 in the Russian Federation. PLoS Med. 2017;14(11): e1002462.
Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010;112(3):178–93.
Zarkin GA, Bray JW, Babor TF, Higgins-Biddle JC. Alcohol drinking patterns and health care utilization in a managed care organization. Health Serv Res. 2004;39(3):553–70.
Kline-Simon AH, Weisner CM, Parthasarathy S, Falk DE, Litten RZ, Mertens JR. Five-year healthcare utilization and costs among lower-risk drinkers following alcohol treatment. Alcohol Clin Exp Res. 2014;38(2):579–86.
Kahler CW, Liu T, Cioe PA, Bryant V, Pinkston MM, Kojic EM, et al. Direct and indirect effects of heavy alcohol use on clinical outcomes in a longitudinal study of HIV patients on ART. AIDS Behav. 2017;21(7):1825–35.
Williams EC, Hahn JA, Saitz R, Bryant K, Lira MC, Samet JH. Alcohol use and human immunodeficiency virus (HIV) infection: current knowledge, implications, and future directions. Alcohol: Clin Exp Res. 2016;40(10):2056–72.
Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009;52(5):611–22.
Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis. Br J Cancer. 2015;112(3):580–93.
Sullivan LE, Goulet JL, Justice AC, Fiellin DA. Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection. Drug Alcohol Depend. 2011;117(2):158–63.
Gordon AJ, McGinnis KA, Conigliaro J, Rodriguez-Barradas MC, Rabeneck L, Justice AC, et al. Associations between alcohol use and homelessness with healthcare utilization among human immunodeficiency virus-infected veterans. Med Care. 2006;44(8):S37-43.
De Boni RB, Peratikos MB, Shepherd BE, Grinsztejn B, Cortés C, Padgett D, et al. Is substance use associated with HIV cascade outcomes in Latin America? PLoS ONE. 2018;13(3):e0194228.
Allan V. Examining the infrastructure of the Russian and USA healthcare systems with respect to the management of HIV patients [Internet]. Ipsos Healthcare, p. 10; 2013. Accessed 24 Apr 2022. https://www.ipsos.com/sites/default/files/publication/1970-01/ipsos-healthcare-hiv-management-in-russia-2013.pdf
Amirkhanian YA, Kelly JA, DiFranceisco WJ, Kuznetsova AV, Tarima SS, Yakovlev AA, et al. Predictors of HIV care engagement, antiretroviral medication adherence, and viral suppression among people living with HIV infection in St. Petersburg, Russia. AIDS Behav. 2018;22(3):791–9.
Tindle HA, Freiberg MS, Gnatienko N, Blokhina E, Cheng DM, Yaroslavtseva T, et al. Design of a randomized controlled trial of smoking cessation medications for alcohol reduction among HIV-positive heavy drinkers and daily smokers in St. Petersburg, Russia. Contemp Clin Trials Commun. 2020;19:100625.
Hedden SL, Kennet J, Lipari R, Medley G, Tice P, Copello EAP, et al. Key substance use and mental health indicators in the United States: results from the 2015 National Survey on Drug Use and Health [Internet]. SAMHSA; 2015, p. 74. https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2015/NSDUH-FFR1-2015/NSDUH-FFR1-2015.pdf
Tindle HA, Freiberg MS, Cheng DM, Gnatienko N, Blokhina E, Yaroslavtseva T, et al. Effectiveness of varenicline and cytisine for alcohol use reduction among people with hiv and substance use: a randomized clinical trial. JAMA Netw Open. 2022;5(8): e2225129.
Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. AUDIT: the alcohol use disorders identification test [Internet]. World Health Organization; 2011, p. 41. https://www.who.int/publications/i/item/audit-the-alcohol-use-disorders-identification-test-guidelines-for-use-in-primary-health-care
Mathew TA, Shields AL, Yanov SA, Golubchikova VT, Strelis AK, Yanova GV, et al. Performance of the alcohol use disorders identification test among tuberculosis patients in Russia. Subst Use Misuse. 2010;45(4):598–612.
Neufeld M, Rehm J, Bunova A, Gil A, Gornyi B, Rovira P, et al. Validation of a screening test for alcohol use, the Russian Federation. Bull World Health Organ. 2021;99(7):496–505.
Broadhead WE, Gehlbach SH, De Gruy FV, Kaplan BH. The Duke–UNC functional social support questionnaire: measurement of social support in family medicine patients. Med Care. 1988;26(7):709–23.
Radloff LS. The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.
Dershem LD, Patsiorkovski VV, O’Brien DJ. The use of the Ces-D for measuring symptoms of depression in three rural Russian villages. Soc Indic Res. 1996;39(1):89–108.
Pecoraro A, Mimiaga MJ, O’Cleirigh C, Safren SA, Blokhina E, Verbitskaya E, et al. Lost-to-care and engaged-in-care HIV patients in Leningrad Oblast, Russian Federation: barriers and facilitators to medical visit retention. AIDS Care. 2014;26(10):1249–57.
Merskey H (ed) Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Pain 1986;Suppl 3:226–226.
Justice A, Modur S, Tate J, Althoff K, Jacobson L, Gebo K, et al. Predictive accuracy of the veterans aging cohort study (VACS) index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr. 2013;62(2):149–63.
Springer SA, Di Paola A, Barbour R, Azar MM, Altice FL. Extended-release Naltrexone improves viral suppression among incarcerated persons living with HIV and alcohol use disorders transitioning to the community: results from a double-blind, placebo-controlled trial. J Acquir Immune Defic Syndr. 2018;79(1):92–100.
Tkatchenko-Schmidt E, Atun R, Wall M, Tobi P, Schmidt J, Renton A. Why do health systems matter? Exploring links between health systems and HIV response: a case study from Russia. Health Policy Plan. 2010;25(4):283–91.
Kuznetsova AV, Meylakhs AY, Amirkhanian YA, Kelly JA, Yakovlev AA, Musatov VB, et al. Barriers and facilitators of HIV care engagement: results of a qualitative study in St. Petersburg, Russia. AIDS Behav. 2016;20(10):2433–43.
Sarang A, Rhodes T, Sheon N. Systemic barriers accessing HIV treatment among people who inject drugs in Russia: a qualitative study. Health Policy Plan. 2013;28(7):681–91.
Popovich L, Potapchik E, Shishkin S, Richardson E, Vacroux A, Mathivet B. Russian Federation Health system review. Health Syst Transit. 2011;13(7):1–190.
Levada-Center. Healthcare system in Russia [Internet]. Accessed 5 Jan 2022. https://www.levada.ru/en/2014/09/19/healthcare-system-in-russia/
Lodi S, Rossi SL, Bendiks S, Gnatienko N, Lloyd-Travaglini C, Vetrova M, et al. Correlates of intersectional HIV and substance use stigma affecting people with HIV and substance use in St. Petersburg, Russia. AIDS Behav. 2022;27:462–72.
Vetrova MV, Cheng DM, Bendiks S, Gnatienko N, Lloyd-Travaglini C, Jiang W, et al. HIV and substance use stigma, intersectional stigma and healthcare among HIV-positive PWID in Russia. AIDS Behav. 2021;25(9):2815–26.
Dudina VI, King EJ, Tsareva AV. Concealing an HIV-positive status in medical settings: discussions in Russian online forums. Qual Health Res. 2020;30(9):1379–91.
Nartova N, Yasaveyev I, Shilova A. People living with HIV and HIV activists (St. Petersburg & Kazan) Russia [Internet], p. 23. Accessed 24 Apr 2022. http://www.promise.manchester.ac.uk/wp-content/uploads/2018/06/People-living-with-HIV-and-HIV-activists.pdf
Funding
This work was supported by grants from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in support of URBAN ARCH: U01AA020780, U24AA020779, U24AA020778. Ms. Biondi and Ms. Freibott are supported by the National Institute of Drug Abuse (T32DA041898).
Author information
Authors and Affiliations
Contributions
BEB: conceptualization, writing—original draft; CEF: review and editing; DMC: methodology, review and editing; EB: review and editing; DL: review and editing; LR: software, formal analysis, review and editing; GP: software, formal analysis, review and editing; SB: project administration, review and editing; NG: project administration, review and editing; HT: review and editing, funding acquisition; MF: review and editing, funding acquisition, EK: review and editing; JHS: review and editing funding acquisition, supervision; MDS: review and editing, supervision.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to disclose.
Ethics Approval
The St PETER study was approved by the Institutional Review Boards of Boston University Medical Campus, Vanderbilt University Medical Center, and Pavlov University.
Consent to Participate
Informed consent was obtained from all participants included in the study.
Consent for Publication
N/a.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Biondi, B.E., Freibott, C.E., Cheng, D.M. et al. Healthcare Utilization Among Persons with HIV and Unhealthy Alcohol Use in St. Petersburg, Russia. AIDS Behav 28, 19–25 (2024). https://doi.org/10.1007/s10461-023-04161-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-023-04161-6